  Pompe disease is an autosomal recessive glycogen storage disorder caused by deficiency of the lysosomal enzyme acid alpha-glucosidase ( GAA). GAA deficiency results in systemic lysosomal glycogen accumulation and cellular disruption in muscle and the central nervous system ( CNS). Adeno-associated virus ( AAV) gene therapy is ideal for Pompe disease , since a single systemic injection may correct both muscle and CNS pathologies. Using the Pompe mouse ( B6; 129-Gaa